1. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Issue 10289 (29th May 2021) Authors: Ridker, Paul M; Devalaraja, Matt; Baeres, Florian M M; Engelmann, Mads D M; Hovingh, G Kees; Ivkovic, Milana; Lo, Larry; Kling, Douglas; Pergola, Pablo; Raj, Dominic; Libby, Peter; Davidson, Michael Journal: Lancet Issue: Volume 397:Issue 10289(2021) Page Start: 2060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗